KE3351A - 6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines - Google Patents

6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines

Info

Publication number
KE3351A
KE3351A KE3351A KE335183A KE3351A KE 3351 A KE3351 A KE 3351A KE 3351 A KE3351 A KE 3351A KE 335183 A KE335183 A KE 335183A KE 3351 A KE3351 A KE 3351A
Authority
KE
Kenya
Prior art keywords
quinazolines
dialkoxy
piperidino
substituted
Prior art date
Application number
KE3351A
Other languages
English (en)
Inventor
Fraser Campbell Simon
Christopher Danilewicz John
Leslie Ham Allan
Kendrick Stubbs John
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of KE3351A publication Critical patent/KE3351A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
KE3351A 1977-11-03 1983-11-21 6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines KE3351A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4566977 1977-11-03

Publications (1)

Publication Number Publication Date
KE3351A true KE3351A (en) 1983-12-16

Family

ID=10438111

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3351A KE3351A (en) 1977-11-03 1983-11-21 6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines

Country Status (24)

Country Link
US (1) US4188391A (xx)
JP (1) JPS5498786A (xx)
AR (2) AR221851A1 (xx)
AT (1) AT366043B (xx)
AU (1) AU506317B2 (xx)
BE (1) BE871769A (xx)
CA (1) CA1086735A (xx)
CH (1) CH637130A5 (xx)
DE (1) DE2847622A1 (xx)
DK (1) DK488078A (xx)
ES (2) ES474763A1 (xx)
FI (1) FI63934C (xx)
FR (1) FR2407926A1 (xx)
HK (1) HK94184A (xx)
IE (1) IE47996B1 (xx)
IL (1) IL55845A (xx)
IT (1) IT1101287B (xx)
KE (1) KE3351A (xx)
LU (1) LU80461A1 (xx)
MY (1) MY8500284A (xx)
NL (1) NL174144C (xx)
PH (1) PH14693A (xx)
PT (1) PT68733A (xx)
SE (1) SE7811323L (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US5614627A (en) * 1993-09-10 1997-03-25 Eisai Co., Ltd. Quinazoline compounds
JP4028894B2 (ja) * 1996-08-09 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 ベンゾピペリジン誘導体
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
MX2009003313A (es) * 2006-10-06 2009-04-09 Bausch & Lomb Acidos quinolona carboxilicos, derivados de los mismos, procesos para su preparacion y su uso como agentes antibacterianos.
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CN113924092A (zh) * 2019-03-19 2022-01-11 斯汀格瑞治疗股份有限公司 喹啉和喹唑啉化合物以及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AR221851A1 (es) 1981-03-31
MY8500284A (en) 1985-12-31
FR2407926A1 (fr) 1979-06-01
CA1086735A (en) 1980-09-30
IL55845A0 (en) 1979-01-31
AU4127778A (en) 1979-05-17
NL7810865A (nl) 1979-05-07
AU506317B2 (en) 1979-12-20
NL174144B (nl) 1983-12-01
DK488078A (da) 1979-05-04
BE871769A (fr) 1979-05-03
PH14693A (en) 1981-11-10
JPS566428B2 (xx) 1981-02-10
HK94184A (en) 1984-12-07
IT7829368A0 (it) 1978-11-02
NL174144C (nl) 1984-05-01
AR221251A1 (es) 1981-01-15
CH637130A5 (de) 1983-07-15
LU80461A1 (fr) 1980-05-07
IE47996B1 (en) 1984-08-22
SE7811323L (sv) 1979-05-04
ES480053A1 (es) 1980-07-16
FI783325A (fi) 1979-05-04
ES474763A1 (es) 1980-12-16
FR2407926B1 (xx) 1982-11-12
FI63934B (fi) 1983-05-31
DE2847622A1 (de) 1979-05-31
US4188391A (en) 1980-02-12
IL55845A (en) 1982-07-30
PT68733A (en) 1978-12-01
IT1101287B (it) 1985-09-28
FI63934C (fi) 1983-09-12
JPS5498786A (en) 1979-08-03
AT366043B (de) 1982-03-10
ATA783878A (de) 1981-07-15

Similar Documents

Publication Publication Date Title
GB2007213B (en) 2,6-diaminoebularins
AU3921478A (en) 3,4,5 trihydroxypiperidine derivatives
ZA785001B (en) 1-phenyl-2-azolyl-4,4-dimethyl-1-penten-3-ols
HK22182A (en) 1-phenyl-3-azabicyclo(3,1,0)hexan-2-ones
KE3351A (en) 6,7-dialkoxy-4-(4-substituted-piperidino)-quinazolines
GB2007643B (en) 4,5-diarylthiazoles
CS526878A2 (en) Zpusob zpracovani pryzoveho odpadu,zejmena opotrebenych automobilovych pneumatik
AU4127478A (en) 6-oxygenated-3,2-dioxo-pregnane-derivatives
PH17238A (en) 1,2,3,4-tetrahydro-2-piperazinyl-napthalenes
IL54358A0 (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides
PT68947A (en) 2,3-dicyanopyrazine derivatives
GB2086882B (en) 2,4-diamino-5-benzyl-6-halogenpyrimidines
GB2086373B (en) 13,14-didehydro-prostaglandins
GB2017104B (en) 4-thia-2,6-diaza-bicyclo-(3,2,0-)-heptane derivatives
GB2001972B (en) Substituted 1-piperazinyl-triazolo-thieno-1,4-diazepines
GB2037770B (en) 3,4,5 - trihydroxy - 5 - (2,3 - epoxy - 5-hydroxy - 4 - methyl - hexyl) - tetra-hydropyran - 2 - yl - acetone
AU3347778A (en) 1,2,4,-benzotriazine-di-n-oxide derivatives
GB1542605A (en) 4-tertiary-amino-2,6-diaminopyridine-1-oxides
IE45999L (en) 2-methoxybenzamides.
GB2008093B (en) 2,6-methano-2h-1-benzoxcins
AU3857578A (en) Biocidally-active 1, 3-benzodithiole-2-thione compounds
GB2001314B (en) 1-aza-1,5,9-cyclododecatrienes
CS375378A1 (en) Zpusob montaze nosnych dilcu uloznych skladovych konstrukci, zejmena skladovych regalu
IE782216L (en) 2,4 - diamino - 5 - benzylpyrimidines
IE822611L (en) 2, 5-disubstituted-3-substituted methyl-penta-2, 4-dienoic¹acids